Kristina Howard, DVM, PhD

Research Veterinary Medical Officer
US FDA
Silver Spring, Maryland, United States

Presentation(s):

• Nonclinical Immunotoxicity Assessment: State of the Science and Future Directions (CE7)

  Sunday, November 17, 2024
  1:00 PM – 4:30 PM CT

• Immunomodulation and Immunostimulation: Risk Identification and Assessment (CE7-3)

  Sunday, November 17, 2024
  2:00 PM – 2:30 PM CT

• Immunogenicity Risk Assessment: Are Preclinical Methods Informative? (S03)

  Monday, November 18, 2024
  9:00 AM – 12:00 PM CT

• Can the Humanized Mouse Model Inform Immunogenicity Risk Assessment? (S03-4)

  Monday, November 18, 2024
  10:45 AM – 11:15 AM CT

• Influence of Vaccine-Induced Anti-PEG Antibodies on In Vitro Measurement of Pegylated Drug Concentrations (P207)

  Monday, November 18, 2024
  5:00 PM – 6:30 PM CT